CLINICAL_TRIALS trial_result · 2023-08-08

Clinical Trial Update: A Study of LAM-002A for the Prevention of Progression of COVID-19 [Phase 2]

Phase 2 trial of LAM-002A for prevention of progression of COVID-19 completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: OrphAI Therapeutics | Conditions: COVID-19 Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-08-08